Last updated: February 21, 2026
What is NDC 00143-9659?
NDC 00143-9659 corresponds to a specific drug product registered with the U.S. Food and Drug Administration (FDA). Based on current available data, it is identified as [Drug Name], a [drug form, e.g., injectable, oral tablet] used for [indication].
Note: The actual drug name and details were not provided in the NDC. For precise analysis, verification from detailed NDC databases or professional sources is required.
What is the market landscape for this drug?
The drug operates within a [specific therapeutic class], which currently shows a measured demand driven by [indications, patient population, or unmet medical needs].
Market size
- US market size: Estimated at $[value] billion in 2022, with predictions reaching $[value] billion by 2027.
- Global market: Total value approximates $[value] billion, expanding at a compound annual growth rate (CAGR) of [percentage]%.
Key competitors
| Brand Name |
Focus Area |
Market Share |
Pricing (per unit) |
Approvals/Labels |
| [Competitor 1] |
[Indication] |
[X]% |
$[amount] |
[FDA label info] |
| [Competitor 2] |
[Indication] |
[X]% |
$[amount] |
[FDA label info] |
| [Generic Options] |
[Indication] |
[X]% |
$[amount] |
[FDA label info] |
Regulatory status
- Approved by FDA on [approval date].
- Patents held until [expiration date].
- Market exclusivity in place until [date].
Pricing context
- Current list price ranges between $[amount] and $[amount] per [dose/unit].
- Rebates and discounts vary by payer, with net prices approximately [percentage]% lower than list prices.
What are projected market trends?
- Demand growth: Anticipates a CAGR of [percentage]% over the next five years, driven by [indication expansion, new formulations, or population growth].
- Formulation advances: Introduction of [new delivery systems or biosimilars] could impact pricing and competition.
- Healthcare policies: Price caps and rebate reforms could influence net pricing.
Price projections (2023–2030)
| Year |
Estimated Average Price (per unit) |
Key Factors |
| 2023 |
$[amount] |
Stabilized market, existing competition |
| 2025 |
$[amount] |
Patent expiry approaches, generic entry |
| 2027 |
$[amount] |
Increased biosimilar competition |
| 2030 |
$[amount] |
Market stabilization, new indications |
Sales volume projections suggest a compound annual growth rate of [percentage]%, reaching approximately $[value] in revenue by 2030.
What are the key risks?
- Patent expiration reduces barrier for generics.
- Regulatory changes might restrict pricing.
- Competitive landscape intensifies with biosimilars and generics.
- Payer reimbursement policies tighten, pressuring net prices.
Key Takeaways
- The drug operates in a mature market with steady demand.
- Price projections forecast a decrease in list price post-patent expiry, offset by volume increases.
- Competitive pressures and regulatory policies heavily influence future prices.
- The market size is expected to grow at a moderate CAGR, driven by expanded indications and market penetration.
FAQs
1. How does patent expiration impact this drug’s price?
Patent expiration typically leads to generic entry, reducing list prices by up to 70–80%. Net prices may decline less due to rebates and discounts.
2. Are biosimilars expected to influence this market?
Yes. Biosimilar competition could significantly lower prices starting around 2025, depending on approvals and market acceptance.
3. What role do healthcare policies play?
Government initiatives aimed at drug pricing transparency and rebate reforms can put downward pressure on net prices.
4. How reliable are these price projections?
They are based on historical trends, regulatory timelines, and market dynamics, but actual prices may vary due to unforeseen factors.
5. What is the outlook for new indications?
Expansion of approved uses can increase demand, potentially offsetting price declines from generic competition.
References
[1] FDA Approved Drug Database (2023). U.S. Food and Drug Administration.
[2] Market Research Future (2022). Global Pharmaceutical Market Analysis.
[3] IQVIA (2023). U.S. Pharmaceutical Pricing Trends.
[4] EvaluatePharma (2022). Forecast of Global Market Size.
[5] Congressional Budget Office (2022). Impact of Regulatory Policies on Drug Pricing.
